PRODUCT

Introduction to Boryung
caring for people’s health

Main Products

A guide to Boryung’ main
products.

Products

A guide to all
Boryung’s products.

close

R&D

The Boryung Company,
envisioning a world with a
healthy mankind.

R&D Vision·Strategy

Boryung’ goal is to develop
into a global company.

Pipeline

The research team at Boryung
aims to lead the future of the
pharmaceutical industry.

close

Investors

The Boryung Company,
envisioning a world with a
healthy mankind.

Financial Information

You can see Boryung’s financial
information.

Stock Information

You can see Boryung’s stock price
information

close

GLOBAL
BUSINESS

An introduction of
Boryung’ global business.

Introduction

The best global company.

CMO

Introducing BRCMO business

Network

50 markets and 150 partners worldwide.

close

PR

An introduction of Boryung ’ value -
Envisioning a healthy mankind.

Advertising

An introduction of video
and printed advertisements of Boryung.

close

Directions

An introduction of Boryung
Pharmaceutical’ value - Envisioning
a healthy mankind.

Directions

An introduction of video
and printed advertisements of Boryung.

close

Financial Information

Summarized finance position table

(Unit : KRW 1,000,000 / As of December 31, 2021)

Summarized finance position table
Financial items 2021 2020 2019
Current asset 437,314 315,660 231,851
Non-current asset 391,327 332,334 275,778
Total assets 828,641 647,994 507,629
Current liability 155,953 122,871 139,214
Non-current liability 198,374 184,835 85,461
Total liabilities 354,327 307,706 224,675
Capital 34,345 23,810 22,100
Other paid-up capital and other components of capital 104,735 20,284 -12,816
Profit earning surplus 334,827 295,816 273,669
Total capital 474,314 340,288 282,954

Summary of comprehensive income statement

(As of December 31, 2021)

Financial items
Financial items 2021 2020 2019
Sales 627,279 561,867 524,269
Cost of sales 362,342 330,425 301,274
Gross margin 264,937 231,442 222,995
Sales management expenses 184,343 155,949 146,067
R&D expenses 39,146 35,506 37,864
Business profits 41,448 39,986 39,064
Financial profits 11,916 658 91
Financial expenses 5,156 4,204 257
Other profits 1,377 1,938 8,965
Other expenses 4,320 2,334 2,655
Profits and loss on investment of relational company 25,453 0 -2,738
Net profit before deducting corporate tax expenses 70,718 36,044 42,469
Corporate tax expenses 27,599 9,184 10,248
Net profit during the term 43,119
26,860 32,222

Major financial ratio

(As of December 31, 2021)

Analysis on profitability
Financial items 2021 2020 2019
Growth rate of sales 11.64% 7.17% 13.87%
Net profit growth rate 60.53% -16.64% 58.67%
ROA 5.84% 4.65% 6.73%
ROE 9.09% 7.89% 11.39%
Debt ratio 74.70% 90.43% 79.40%
Reserve ratio 974.89% 1242.40% 1238.32%
Interest compensation ratio (times) 8.04 9.51 151.92

Analysis on profitability

(As of December 31, 2021)

Analysis on profitability
Financial items 2021 2020 2019
Gross profit ratio 42.24% 41.19% 42.53%
R&D investment ratio 6.24% 6.32% 7.22%
Marketing Management ratio 29.39% 27.76% 27.86%
Sales profit ratio 6.61% 7.12% 7.45%
Net profit ratio during the term 6.87% 4.78% 6.15%
TOP